Parametric Portfolio Associates’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Parametric Portfolio Associates’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$102K	Sell	2,045 -1,253	-38%	-$61.9K	﹤0.01%	3559
2021 Q4	$232K	Sell	3,298 -1,133	-26%	-$95.5K	﹤0.01%	3368
2021 Q3	$413K	Sell	4,431 -30	-0.7%	-$2.85K	﹤0.01%	3181
2021 Q2	$448K	Sell	4,461 -138	-3%	-$13.5K	﹤0.01%	3132
2021 Q1	$429K	Buy	4,599 +2,238	+95%	+$227K	﹤0.01%	3568
2020 Q4	$195K	Buy	2,361 +874	+59%	+$74.5K	﹤0.01%	3784
2020 Q3	$128K	Buy	1,487 +1,013	+214%	+$118K	﹤0.01%	3748
2020 Q2	$44K	Buy	+474	New	+$26.1K	﹤0.01%	3873

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Parametric Portfolio Associates's VBIV Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) stake by 38% in Q1 2022, selling an estimated $61.9K and leaving 2,045 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #3559.

Parametric Portfolio Associates first reported a position in VBIV in Q2 2020 and has held it in 8 quarters since. The position peaked at $448K in Q2 2021. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

Parametric Portfolio Associates held 2,045 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $102K as of Q1 2022.
Parametric Portfolio Associates sold 1,253 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022, an estimated $61.9K.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3559 holding.
Parametric Portfolio Associates first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and has held it in 8 quarters since.
Parametric Portfolio Associates's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $448K in Q2 2021.
131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.